Akeso Therapeutics

Akeso Therapeutics is an early-stage biotechnology company developing engineered Natural Killer T (NKT) cells for cancer treatment. Akeso Therapeutics, Inc. operates in stealth mode, focusing on the development of Chimeric Antigen Receptors (CAR) designed for off-the-shelf allogeneic NKT cell therapies targeting cancer. By leveraging its NKT cell expansion platform and two proprietary patents, Akeso Therapeutics is advancing allogeneic Type I and Type III NKT cell therapies.